盐酸罗匹尼罗结构式
|
常用名 | 盐酸罗匹尼罗 | 英文名 | Ropinirole hydrochloride |
|---|---|---|---|---|
| CAS号 | 91374-20-8 | 分子量 | 296.836 | |
| 密度 | N/A | 沸点 | 410.5ºC at 760mmHg | |
| 分子式 | C16H25ClN2O | 熔点 | 241-243ºC | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07, GHS09 |
信号词 | Warning |
盐酸罗匹尼罗用途Ropinirole(SKF101468)盐酸盐是多巴胺受体D2抑制剂,IC50为29 nM。 |
| 中文名 | 4-(2-二正丙基胺乙基)-1,3-二氯-2H-吲哚-2-酮 |
|---|---|
| 英文名 | 4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride |
| 中文别名 | 4-[2-二正丙基胺乙基]-1,3-二氢-2H-吲哚-2-酮盐酸盐 | 盐酸罗匹尼罗 | 盐酸罗匹尼罗 |
| 英文别名 | 更多 |
| 描述 | Ropinirole(SKF101468)盐酸盐是多巴胺受体D2抑制剂,IC50为29 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 410.5ºC at 760mmHg |
|---|---|
| 熔点 | 241-243ºC |
| 分子式 | C16H25ClN2O |
| 分子量 | 296.836 |
| 精确质量 | 296.165527 |
| PSA | 32.34000 |
| LogP | 3.78570 |
| 外观性状 | 灰白色固体 |
| 储存条件 | Room temp |
| 符号 |
GHS07, GHS09 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H400 |
| 警示性声明 | P301 + P312 + P330 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| 危害码 (欧洲) | Xn,N |
| 风险声明 (欧洲) | R22 |
| 安全声明 (欧洲) | 36-60-61-37/39-26 |
| 危险品运输编码 | UN 3077 9/PG 3 |
| RTECS号 | NM3288250 |
| 危险类别 | 9.0 |
| 海关编码 | 2933790090 |
|
~89%
盐酸罗匹尼罗 91374-20-8 |
| 文献:IND-SWIFT LABORATORIES LIMITED Patent: WO2008/84499 A1, 2008 ; Location in patent: Page/Page column 8 ; |
|
~50%
盐酸罗匹尼罗 91374-20-8 |
| 文献:TORRENT PHARMACEUTICALS LTD Patent: WO2005/80333 A1, 2005 ; Location in patent: Page/Page column 23 ; |
|
~%
盐酸罗匹尼罗 91374-20-8 |
| 文献:WO2011/30330 A2, ; Page/Page column 9 ; |
|
~%
盐酸罗匹尼罗 91374-20-8 |
| 文献:WO2005/40115 A1, ; Page/Page column 6 ; |
|
~40%
盐酸罗匹尼罗 91374-20-8 |
| 文献:Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1568689 A1, 2005 ; Location in patent: Page/Page column 7 ; |
|
~85%
盐酸罗匹尼罗 91374-20-8 |
| 文献:Hayler, John D.; Howie, Simon L. B.; Giles, Robert G.; Negus, Alan; Oxley, Paul W.; Walsgrove, Timothy C.; Whiter Organic Process Research and Development, 1998 , vol. 2, # 1 p. 3 - 9 |
|
~%
盐酸罗匹尼罗 91374-20-8 |
| 文献:WO2011/72704 A1, ; |
|
~%
盐酸罗匹尼罗 91374-20-8 |
| 文献:Organic Process Research and Development, , vol. 2, # 1 p. 3 - 9 |
|
~%
盐酸罗匹尼罗 91374-20-8 |
| 文献:Organic Process Research and Development, , vol. 2, # 1 p. 3 - 9 |
| 盐酸罗匹尼罗上游产品 10 | |
|---|---|
| 盐酸罗匹尼罗下游产品 1 | |
| 海关编码 | 2933790090 |
|---|---|
| 中文概述 | 2933790090 其他内酰胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:9.0% 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933790090. other lactams. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:9.0%. General tariff:20.0% |
|
Sustained release microspheres of ropinirole hydrochloride: effect of process parameters.
Acta. Pharm. 61 , 363-376, (2011) An emulsion solvent evaporation method was employed to prepare microspheres of ropinirole hydrochloride, a highly water soluble drug, by using ethylcellulose and PEG with the help of 32 full factorial... |
|
|
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
Neurobiol. Dis. 47(3) , 393-406, (2012) Dyskinesia seen in the off-state, referred as graft-induced dyskinesia (GID), has emerged as a serious complication induced by dopamine (DA) cell transplantation in parkinsonian patients. Although the... |
|
|
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization.
J. Med. Chem. 55(12) , 5826-40, (2012) In our effort to develop multifunctional drugs against Parkinson's disease, a structure-activity-relationship study was carried out based on our hybrid molecular template targeting D2/D3 receptors. Co... |
| 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-, hydrochloride (1:1) |
| 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
| 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride (1:1) |
| 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-onhydrochlorid |
| UNII-D7ZD41RZI9 |
| ropinirole hcl |
| 4-[2-(dipropylamino)éthyl]-1,3-dihydro-2H-indol-2-one chlorhydrate |
| Adartrel |
| MFCD01754173 |
| Ropinirole hydrochloride |
| 2H-indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-, monohydrochloride |
| Requip |
| Ropinirole (hydrochloride) |